SHANDONG TEAMGENE TECHNOLOGY CO., LTD. — Investor Relations & Filings
About SHANDONG TEAMGENE TECHNOLOGY CO., LTD.
Shandong Teamgene Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced veterinary diagnostic products and molecular biology reagents. The company focuses on providing comprehensive solutions for animal health management, particularly in the detection and control of infectious diseases in livestock and poultry. Its product portfolio includes high-precision PCR test kits, nucleic acid extraction systems, and rapid diagnostic reagents designed for pathogens such as African Swine Fever and avian influenza. Teamgene serves a diverse clientele, including large-scale breeding enterprises, veterinary laboratories, and animal epidemic prevention centers. By leveraging biotechnology innovations, the company delivers technical support and diagnostic tools aimed at improving biosecurity and animal welfare within the agricultural sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 山东邦基科技股份有限公司2025年年度股东会决议公告 | 2026-05-11 | Chinese | |
| 山东邦基科技股份有限公司关于公司对外担保的进展公告 | 2026-05-08 | Chinese | |
| 山东邦基科技股份有限公司2025年年度报告全文 | 2026-04-20 | Chinese | |
| 山东邦基科技股份有限公司2025年度董事会审计委员会履职情况报告 | 2026-04-20 | Chinese | |
| 关于山东邦基科技股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告 | 2026-04-20 | Chinese | |
| 山东邦基科技股份有限公司关于提请股东会授权董事会制定中期分红方案的公告 | 2026-04-20 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45018017 | 山东邦基科技股份有限公司2025年年度股东会决议公告 | 2026-05-11 | Chinese | ||
| 44492813 | 山东邦基科技股份有限公司关于公司对外担保的进展公告 | 2026-05-08 | Chinese | ||
| 39560604 | 山东邦基科技股份有限公司2025年年度报告全文 | 2026-04-20 | Chinese | ||
| 39560603 | 山东邦基科技股份有限公司2025年度董事会审计委员会履职情况报告 | 2026-04-20 | Chinese | ||
| 39560594 | 关于山东邦基科技股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告 | 2026-04-20 | Chinese | ||
| 39560576 | 山东邦基科技股份有限公司关于提请股东会授权董事会制定中期分红方案的公告 | 2026-04-20 | Chinese | ||
| 39560565 | 山东邦基科技股份有限公司关于公司对外担保的进展公告 | 2026-04-07 | Chinese | ||
| 39560564 | 山东邦基科技股份有限公司关于2024年股票期权激励计划首次授予股票期权2026年第一季度自主行权结果暨股份变动公告 | 2026-04-01 | Chinese | ||
| 39560562 | 山东邦基科技股份有限公司关于2024年股票期权激励计划首次授予部分第一个行权期限制行权期间的提示性公告 | 2026-03-25 | Chinese | ||
| 39560548 | 山东邦基科技股份有限公司关于变更持续督导保荐代表人的公告 | 2026-03-17 | Chinese | ||
| 39560547 | 山东邦基科技股份有限公司关于公司对外担保的进展公告 | 2026-03-05 | Chinese | ||
| 39560532 | 山东邦基科技股份有限公司2026年第一次临时股东会决议公告 | 2026-02-24 | Chinese | ||
| 39560520 | 北京德和衡律师事务所关于山东邦基科技股份有限公司2026年第一次临时股东会的法律意见书 | 2026-02-24 | Chinese | ||
| 39560499 | 山东邦基科技股份有限公司2026年第一次临时股东会会议资料 | 2026-02-06 | Chinese | ||
| 39560464 | 山东邦基科技股份有限公司关于公司对外担保的进展公告 | 2026-02-06 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHANDONG TEAMGENE TECHNOLOGY CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57461/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57461 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57461 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57461 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57461}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHANDONG TEAMGENE TECHNOLOGY CO., LTD. (id: 57461)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.